RxDoctor Payments Data

Wilson Molina, MD

Urology · Kansas City, KSNPI 1285867473

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (32.5%), consulting fees and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 43.8% of the total. Among urology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$239,290in general payments, 2019–2025

Across 285 payments — averaging $839.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$105K
  • Olympus Corporation Of The Americas$36K
  • Gyrus ACMI, Inc.$28K
  • Johnson & Johnson$23K
  • Olympus Latin America, Inc.$18K
  • KARL Storz Endoscopy-america$15K
  • plus $15K from 13 others
$273,422in research payments, 2019–2025

Across 26 payments — averaging $10,516 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gyrus ACMI, Inc.$183K
  • Boston Scientific$85K
  • KARL Storz Endoscopy-america$5K

What the payments were for

  • Royalty or licence$20,7089%
  • Consulting fees$52,80922%
  • Speaking & faculty fees$77,78533%
  • Travel & lodging$35,94515%
  • Food & beverage$6,5923%
  • Education$45,45119%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$239,290 in reported general payments places this provider in the 95th percentile of 111 urology providers in Kansas.

See all urology providers in Kansas

Medicare billing

Part B allowed, 2024
$80,114
Medicare patients
188
Services billed
399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Citrate ErPotassium Citrate20$2,481
Tamsulosin Hcl29$357
Finasteride13$203
Levofloxacin20$76

Paid to pharmacies, not to this prescriber.

Other urology in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →